It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Moderna

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Moderna starts trial for omicron-specific booster shot

World Jan 27, 2022

Moderna starts trial for omicron-specific booster shot

The news comes a day after rival vaccine developer Pfizer Inc. launched a similar trial.

The decades of discoveries before the ‘miraculous’ sprint to a vaccine

World / Science & Health Jan 16, 2022

The decades of discoveries before the ‘miraculous’ sprint to a vaccine

by Gina Kolata and Benjamin Mueller

The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.

Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate

World / Science & Health Jan 11, 2022

Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate

by Low De Wei

While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac’s and Sinopharm Group’s shots, which have been widely used in the developing world.

The ins and outs of Japan's COVID-19 booster shot rollout

National | EXPLAINER Jan 6, 2022

The ins and outs of Japan's COVID-19 booster shot rollout

by Osamu Tsukimori

Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?

Moderna says its booster dose appears protective against omicron

World / Science & Health Dec 20, 2021

Moderna says its booster dose appears protective against omicron

The data, which has not yet been peer reviewed, tested blood from people who had received the vaccine against a pseudovirus engineered to resemble the omicron variant.

Moderna to produce millions of mRNA vaccines in Australia

Business Dec 14, 2021

Moderna to produce millions of mRNA vaccines in Australia

The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats.

What’s worst about omicron so far is the uncertainty

Commentary / World Dec 1, 2021

What’s worst about omicron so far is the uncertainty

by Andreas Kluth

How should the world respond to omicron? We just have to wait as there is information that we don’t yet have. And for many, the waiting itself is the problem.

Moderna says new vaccine for omicron may be ready in early 2022

World / Science & Health Nov 28, 2021

Moderna says new vaccine for omicron may be ready in early 2022

Moderna's chief medical officer says the company should know about the ability of the current vaccine to provide protection in the next couple of weeks.

Japan to make some exceptions to eight-month guideline for COVID-19 booster shots

National Nov 27, 2021

Japan to make some exceptions to eight-month guideline for COVID-19 booster shots

Elderly people in care homes and patients at hospitals hit by cluster infections could receive booster shots six months after their second doses.

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

Commentary / World Nov 26, 2021

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

by Therese Raphael

It's suggested that Britain’s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?

Takeda applies for approval of Moderna's booster shots in Japan

National Nov 12, 2021

Takeda applies for approval of Moderna's booster shots in Japan

A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.

Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble

Business / Corporate Nov 4, 2021

Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble

Moderna said it was now expecting sales of between $15 billion and $18 billion from $20 billion estimated previously.

« 1 2 3 … 9 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times